USP26 and breast carcinoma: Interestingly, the authors found that USP26 expression was lost or amplified in 1,457 and 309 cancer cell lines, respectively, strongly suggesting that the function of USP26 in the TGF‐β pathway may be observed in other cancers besides glioblastoma and breast cancer.